Association	O
of	O
Metabolites	B:C0870883
with	O
Obesity	B:C0028754
and	O
Type	B:C0011860
2	I:C0011860
Diabetes	I:C0011860
Based	O
on	O
FTO	B:C1970415
Genotype	O
.	O

The	O
single	B:C0752046
nucleotide	I:C0752046
polymorphism	I:C0752046
rs9939609	B:C1970415
of	I:C1970415
the	I:C1970415
gene	I:C1970415
FTO	I:C1970415
,	O
which	O
encodes	O
fat	O
mass	O
and	O
obesity	B:C0028754
-	O
associated	O
protein	B:C0033684
,	O
is	O
strongly	O
associated	O
with	O
obesity	B:C0028754
and	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
(	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
)	O
in	O
multiple	O
populations	B:C1257890
;	O
however	O
,	O
the	O
underlying	O
mechanism	O
of	O
this	O
association	O
is	O
unclear	O
.	O

The	O
present	O
study	B:C2603343
aimed	O
to	O
investigate	O
FTO	B:C1970415
genotype	O
-	O
dependent	O
metabolic	B:C0025519
changes	O
in	O
obesity	B:C0028754
and	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
.	O

To	O
elucidate	O
metabolic	O
dysregulation	O
associated	O
with	O
disease	B:C0012655
risk	I:C0012655
genotype	O
,	O
genomic	B:C0150098
and	O
metabolomic	B:C0150098
datasets	I:C0150098
were	O
recruited	O
from	O
2,577	O
participants	B:C0679646
of	O
the	O
Korean	B:C0599755
Association	I:C0599755
REsource	I:C0599755
(	I:C0599755
KARE	I:C0599755
)	I:C0599755
cohort	I:C0599755
,	O
including	O
40	O
homozygous	O
carriers	B:C0007294
of	O
the	O
FTO	B:C1970415
risk	O
allele	B:C0002085
(	I:C0002085
AA	I:C0002085
)	I:C0002085
,	O
570	O
heterozygous	O
carriers	B:C0007294
(	O
AT	O
)	O
,	O
and	O
1,967	O
participants	B:C0679646
carrying	O
no	O
risk	O
allele	B:C0002085
(	I:C0002085
TT	I:C0002085
)	I:C0002085
.	O

A	O
total	O
of	O
134	O
serum	B:C0229671
metabolites	B:C0870883
were	O
quantified	O
using	O
a	O
targeted	O
metabolomics	B:C1328813
approach	O
.	O

Through	O
comparison	O
of	O
various	O
statistical	B:C1710191
methods	I:C1710191
,	O
seven	O
metabolites	B:C0870883
were	O
identified	O
that	O
are	O
significantly	O
altered	O
in	O
obesity	B:C0028754
and	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
based	O
on	O
the	O
FTO	B:C1970415
risk	O
allele	B:C0002085
(	O
adjusted	O
p	O
<	O
0.05	O
)	O
.	O

These	O
identified	O
metabolites	B:C0870883
are	O
relevant	O
to	O
phosphatidylcholine	B:C1959616
metabolic	O
pathway	O
,	O
and	O
previously	O
reported	O
to	O
be	O
metabolic	B:C1513159
markers	I:C1513159
of	O
obesity	B:C0028754
and	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
.	O

In	O
conclusion	O
,	O
using	O
metabolomics	B:C1328813
with	O
the	O
information	O
from	O
genome	B:C2350277
-	I:C2350277
wide	I:C2350277
association	I:C2350277
studies	I:C2350277
revealed	O
significantly	O
altered	O
metabolites	B:C0870883
depending	O
on	O
the	O
FTO	B:C1970415
genotype	O
in	O
complex	O
disorders	O
.	O

This	O
study	B:C2603343
may	O
contribute	O
to	O
a	O
better	O
understanding	O
of	O
the	O
biological	O
mechanisms	O
linking	O
obesity	B:C0028754
and	O
type	B:C0011860
2	I:C0011860
diabetes	I:C0011860
.	O

